JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weissberg, D.
Right arrow Articles by Ben-Zeev, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weissberg, D.
Right arrow Articles by Ben-Zeev, I.

The Journal of Thoracic and Cardiovascular Surgery, Vol 106, 689-695, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Talc pleurodesis. Experience with 360 patients

D Weissberg and I Ben-Zeev
Department of Thoracic Surgery, Tel Aviv University Sackler School of Medicine, E. Wolfson Medical Center, Holon, Israel.

Talc was used intrapleurally for the creation of pleural adhesions in 360 patients. The indications for use were malignant pleural effusion in 169 patients, benign effusions in 41, recurrent pneumothorax in 122, empyema in 19, and chylothorax in 9. Of 336 patients available for follow-up, excellent results (complete pleurodesis) were achieved in 284 patients (84.5%), fair results in 28 (8.3%), and poor results (no adhesions) in 24 (7.2%). The results were best in empyema (100%) and better in pneumothorax than in pleural effusions. With repeat talc insufflation, the results were improved to excellent in more than 90% of the patients. Talc is the most effective and least expensive agent for creation of pleural adhesions. Its use is simple and easily tolerated by the patients. Because of the carcinogenic effect of asbestos, purified talc that is free of asbestos fibers must be used.


This article has been cited by other articles:


Home page
ChestHome page
C. A. Jimenez, A. D. Mhatre, C. H. Martinez, G. A. Eapen, A. Onn, and R. C. Morice
Use of an Indwelling Pleural Catheter for the Management of Recurrent Chylothorax in Patients With Cancer
Chest, November 1, 2007; 132(5): 1584 - 1590.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. A. Kvale, P. A. Selecky, and U. B. S. Prakash
Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 368S - 403S.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. K. Nair, M. Petko, and M. P. Hayward
Aetiology and management of chylothorax in adults
Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 362 - 369.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Noppen
Who's (still) afraid of talc?
Eur. Respir. J., April 1, 2007; 29(4): 619 - 621.
[Full Text] [PDF]


Home page
ICVTSHome page
T. Laisaar, V. Palmiste, T. Vooder, and T. Umbleja
Life expectancy of patients with malignant pleural effusion treated with video-assisted thoracoscopic talc pleurodesis
Interactive CardioVascular and Thoracic Surgery, June 1, 2006; 5(3): 307 - 310.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
N. A. Avila, A. J. Dwyer, A. Rabel, R. M. DeCastro, and J. Moss
CT of Pleural Abnormalities in Lymphangioleiomyomatosis and Comparison of Pleural Findings After Different Types of Pleurodesis.
Am. J. Roentgenol., April 1, 2006; 186(4): 1007 - 1012.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. M. Dresler, J. Olak, J. E. Herndon II, W. G. Richards, E. Scalzetti, S. B. Fleishman, K. H. Kernstine, T. Demmy, D. M. Jablons, L. Kohman, et al.
Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion
Chest, March 1, 2005; 127(3): 909 - 915.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. A. Maskell, Y. C. G. Lee, F. V. Gleeson, E. L. Hedley, G. Pengelly, and R. J. O. Davies
Randomized Trials Describing Lung Inflammation after Pleurodesis with Talc of Varying Particle Size
Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 377 - 382.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Marchi, F. S. Vargas, M. M. P. Acencio, L. Antonangelo, L. R. Teixeira, E. H. Genofre, and R. W. Light
Talc and Silver Nitrate Induce Systemic Inflammatory Effects During the Acute Phase of Experimental Pleurodesis in Rabbits
Chest, June 1, 2004; 125(6): 2268 - 2277.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. H. Kwek, S. L. Aquino, and A. J. Fischman
Fluorodeoxyglucose Positron Emission Tomography and CT After Talc Pleurodesis
Chest, June 1, 2004; 125(6): 2356 - 2360.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G Antunes, E Neville, J Duffy, and N Ali
BTS guidelines for the management of malignant pleural effusions
Thorax, May 1, 2003; 58(90002): ii29 - 38.
[Full Text]


Home page
ChestHome page
R. W. Light
Talc for Pleurodesis?
Chest, November 1, 2002; 122(5): 1506 - 1508.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
E. M. Marom, J. J. Erasmus, J. E. Herndon II, C. Zhang, and H. P. McAdams
Usefulness of Imaging-Guided Catheter Drainage and Talc Sclerotherapy in Patients with Metastatic Gynecologic Malignancies and Symptomatic Pleural Effusions
Am. J. Roentgenol., July 1, 2002; 179(1): 105 - 108.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
V.B. Antony, R. Loddenkemper, P. Astoul, C. Boutin, P. Goldstraw, J. Hott, F. Rodriguez Panadero, and S.A. Sahn
Management of malignant pleural effusions
Eur. Respir. J., August 1, 2001; 18(2): 402 - 419.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. W. Light
Talc Should Not Be Used for Pleurodesis
Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2024 - 2026.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
Management of Malignant Pleural Effusions
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1987 - 2001.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. H. DIACON, C. WYSER, C. T. BOLLIGER, M. TAMM, M. PLESS, A. P. PERRUCHOUD, and M. SOLER
Prospective Randomized Comparison of Thoracoscopic Talc Poudrage under Local Anesthesia versus Bleomycin Instillation for Pleurodesis in Malignant Pleural Effusions
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1445 - 1449.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Weissberg and Y. Refaely
Pneumothorax
Chest, May 1, 2000; 117(5): 1279 - 1285.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Glazer, N. Berkman, J. S. Lafair, and M. R. Kramer
Successful Talc Slurry Pleurodesis in Patients With Nonmalignant Pleural Effusion
Chest, May 1, 2000; 117(5): 1404 - 1409.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. C. Werebe, R. Pazetti, J. R. Milanez de Campos, P. P. Fernandez, V. L. Capelozzi, F. B. Jatene, and F. S. Vargas
Systemic Distribution of Talc After Intrapleural Administration in Rats
Chest, January 1, 1999; 115(1): 190 - 193.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. M. Marom, E. F. Patz Jr, J. J. Erasmus, H. P. McAdams, P. C. Goodman, and J. E. Herndon
Malignant Pleural Effusions: Treatment with Small-Bore-Catheter Thoracostomy and Talc Pleurodesis
Radiology, January 1, 1999; 210(1): 277 - 281.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
D. Weissberg and Y. Refaely
Pleural Empyema: 24-Year Experience
Ann. Thorac. Surg., October 1, 1996; 62(4): 1026 - 1029.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The American Association for Thoracic Surgery.